Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements - Summary of Potentially Dilutive Securities (Details) - shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Net Earnings per Share | ||
| Antidilutive securities (in shares) | 7,064,698 | 20,308,486 |
| Common stock issuable upon exercise of pre-funded warrants | ||
| Net Earnings per Share | ||
| Warrants outstanding (in shares) | 0 | 7,311,000 |
| Options to Purchase Common Stock | ||
| Net Earnings per Share | ||
| Antidilutive securities (in shares) | 1,367,493 | 1,311,691 |
| Unvested Restricted Stock Awards | ||
| Net Earnings per Share | ||
| Antidilutive securities (in shares) | 891 | 891 |
| Unvested Restricted Stock Units | ||
| Net Earnings per Share | ||
| Antidilutive securities (in shares) | 287,400 | 125,000 |
| Convertible Preferred Stock | ||
| Net Earnings per Share | ||
| Antidilutive securities (in shares) | 1,363,636 | 1,363,636 |
| Warrants to Purchase Common Stock | ||
| Net Earnings per Share | ||
| Antidilutive securities (in shares) | 4,045,278 | 17,507,268 |